Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd
Status: Publicly traded
Direct answer
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd is publicly traded on SHH under the ticker 603707.SS.
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (NKBP) operates as a manufacturer and distributor of pharmaceutical goods, with a core focus on heparin sodium and its low molecular weight derivatives. Domestically, the company supplies these critical compounds to pharmaceutical firms across the People's Republic of China. Its product range notably includes injectable forms like enoxaparin sodium, dalteparin...
Can you invest in Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd?
Yes. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd trades publicly on SHH as 603707.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd
Detailed equity research is provided by MarketSnap.